Business Memo
John Carlisle, CEO
Attn: Plant construction
First and foremost, allow me to convey my apologies on behalf of the Environmental Committee for the delay in relaying this communication regarding the contamination at the plant. We would have ideally liked to contact earlier you regarding the nature of the contamination at the new construction site. But all reports have been inconclusive regarding the location of the contamination. We know how valuable your time is and did not want to distract you with reports that did not offer you a definitive solution.
Because of the unclear results, the company conducting the review, Earth Tech, is currently recommending a third study. It says it may have discovered evidence of groundwater contamination, which is very time-consuming and costly to clean up, but once again this is uncertain and it does not want to make a recommendation that could be expensive and ultimately ineffective.
Earth Tech's efforts should be commended in the interests of facilitating the speed of this project. But we on the Environmental Committee believe that consulting another environmental company would be recommended if a last and final study is embarked upon, to gain an alternative perspective on the situation. Environmental testing is a new field, and every company brings its own perspective and 'toolbox' when doing an on-site scan.
However, if the final report is still uncertain, given the timely nature of the project, it may be wise that another venue is solicited. All new drugs have a limited first-mover advantage. Competitor companies are always researching alternative treatments, and it is imperative that this project be started soon. Until a final site is determined, the engineering and customization of the plant equipment necessary to manufacture the new drug must continue.
You’re 69% through this paper. Sign up to read the full paper.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.